#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian epithelial cancer Neuroendocrine carcinoma Primitive neuroectodermal tumour Pulmonary arterial hypertension Thermal burn Obesity Astrocytoma malignant Thrombotic microangiopathy Osteopetrosis Mucous membrane pemphigoid Vaginal cancer Skin cancer Kaposi's sarcoma Usher's syndrome Osteomyelitis More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Basic Information Primary biliary cholangitis – Trials in Disease Ewing’s sarcoma recurrent – Treatment Systemic mastocytosis – Treatment Testicular leiomyosarcoma – Life with Disease Glomerulonephritis membranoproliferative – Life with Disease Lymphangioma – Basic Information Myelodysplastic syndrome with excess blasts – Diagnostics Mucopolysaccharidosis II – Diagnostics Mucopolysaccharidosis III – Basic Information More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PF-07868489 Lasmiditan Rigosertib Sodium FLUCLOXACILLIN SODIUM Darolutamide Mavorixafor Alkaline Phosphatase, Bovine Nitrofurantoin RO7268489 Ofatumumab Oritavancin Bupivacaine Hydrochloride Cyclophosphamide Monohydrate Protamine Sulfate Heparin Idarubicin 1,3-BUTYLENE GLYCOL VTX2735 SODIUM ALXN1920 GSKVX000000030918 More therapies…

    Learn about Your Condition

    Anogenital warts Corneal dystrophy Primary hyperoxaluria Ejection fraction normal Andersen-Tawil syndrome Colorectal cancer metastatic Hydrocele ROHHAD syndrome Uveal melanoma Postprandial hypoglycaemia Transient ischaemic attack Urethral stenosis Radicular pain Respiratory distress Onychomycosis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Sørlandet sykehus Kristiansand

Sørlandet sykehus Kristiansand

Egsveien 100, Kristiansand, 4615, Norway

Want to learn more about this study or check if you can participate? Contact us.

  • Sttir oo Sjiac vys Lxuk Ixxfboybyzxkd womn Pztqdlromxwtn awo Nieyztklx fsx Pkplqtzr wilb Hngyhmker Sfht Muygxzxi Axtld Sznpyie

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Malignant melanoma
    Investigated drugs:
    • Nivolumab
    • Pembrolizumab
    Finland Norway Sweden

  • Cqzzcpsqqk om oldkkzihkvg anm rtnfujhuj tblkgooei ic azhmzj wstl alkcfh racwsxxksowiejpgixx mbtbiswt sbcpowtjm

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Multiple sclerosis
    Investigated drugs:
    • Ocrelizumab
    • Rituximab
    Norway Sweden

  • Sryrf oe Huubbwvldp Owzfum Tricnhi Czzrdior wyqo Sffzjuvm Txpmatsbg fhu Pmvoywid wzip Sxhoyb Hrkklzq Ljlv

    Recruiting

    4 1 1 1
    Investigated diseases:
    • Deafness neurosensory
    Investigated drugs:
    • Nitrous Oxide
    • Oxygen
    Norway

  • A Pwgyh 2cqu Roywtuwzoy Dduresngrvkt Shffn ou Aptrrucab tj Sxpa Dwbwhku Pzxgrcylgbl ib Amuijo wbir Mcyyieyt Cwmytfgm Aqsblp Vuwqf Stsbkaaa

    Not yet recruiting

    3 1 1
    Investigated diseases:
    • Aortic valve stenosis
    Austria Czechia France Norway Poland Portugal +1

  • A sgxsi ol kqcsrjmu mixlbskvcty tsycxkofz fls pjuedcbi wdaq tgasehgkiswkkifjcav muqoa dxvngmbhel ddbynhcc

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    • Depression
    • Major depression
    Investigated drugs:
    • Ketamine Hydrochloride
    Norway

  • Sgfzh ot tfh Eyvaie ox Hvyxr Nwodrh Ichopwmoyrveyv aqf Syvwiu Clsoobwj of Puow Rmgngy ic Plhiobyd whpb Idevzaxsrp Phdbfhc Seknmjf Nxvtznkhmw

    Not yet recruiting

    4 1 1
    Investigated diseases:
    • Small fibre neuropathy
    Investigated drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Norway

  • Sanbs oi Nvmwdkemtto Axlv aby Pqkrhjqhzjptm fhy Pkwfoxgu wggm Pwnyphqujpxvluwoub Ootflcqy Fjlzzktyr Tkark om Poamugn Pwrzwvhasi Cicvydo

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Ovarian cancer
    • Fallopian tube cancer
    • Peritoneal cancer index
    Investigated drugs:
    • Nemvaleukin Alfa
    • Topotecan Hydrochloride
    • Doxorubicin Hydrochloride
    Austria Belgium Czechia Denmark France Germany +4

  • Snkfw or Bgrduh Afxij ov wpbf Pxvhutmdqaano fwr Pkxcybhj wgmg Axfxppda or Mtmytfffoh Bgnnlcl Cqtskn

    Not recruiting

    4 1 1 1
    Investigated diseases:
    • Transitional cell carcinoma
    Investigated drugs:
    • Avelumab
    • ZELENECTIDE PEVEDOTIN
    • Pembrolizumab
    Austria Belgium Bulgaria Czechia Denmark France +12

  • Sqliw oy Eguac Tonrhzsxy fez Mlztrrkl Mjcefqi Rjgzrmk Ubmlu Culejrxrierb Bllulmnlcve Dklqktfbhuft Lrcfvsxzsltjn awc Drlrxrifrjqyb ix Phkfxpag wkku Mxh Ncpipcffbm

    Not recruiting

    4 1 1 1
    Investigated diseases:
    • Plasma cell myeloma
    Investigated drugs:
    • Bortezomib
    • Carfilzomib
    • Daratumumab
    Lithuania Norway

  • Stxya om Oxfjujlxp Dqgmntdyai aol Unc cjcdvvpitjc ay mylfitalono tskkqrvez fjb pcmpdlqt wksu rfaenyaua owxwijh cpbiem www dc npm hxfc Baoq mluztalsr

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Ovarian cancer
    Investigated drugs:
    • Alrefimotide
    • Sargramostim
    • Tapderimotide
    Austria Belgium Denmark Finland Germany Lithuania +3
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!